Case Presentation HKC 1392. A 78 y/o man obstructive symptoms Flank pain(_) Gross hematuria(-). LUTS(+)

Slides:



Advertisements
Similar presentations
A Case Study GP Masterclass Catherine Dale, RN, BSc Cancer Care
Advertisements

BREAST CANCER CASE STUDY FRAZER BELL STUDENT BMS BSc APPLIED BIOMEDICAL SCIENCE.
PROSTATE CANCER Dr Samad Zare Assistant Proffesor of Urology Shaheed Sadoughi University of Medical Sciences.
Case 1: George Case 1: George
Supervised by: Dr- Al Traifi. Why LUTS? What are the symptoms? Common causes? Patient work up Details of the Common etiology BPH.
MODULE 5 1/33 Case 5: Sam. MODULE 5 Case 5: Sam 2/33 Patient History  Sam is a 66 year old retired painter & construction worker.  He is distressed.
MODULE 5 1/40 Case 3: Chuck. MODULE 5 Case 3: Chuck 2/40 Patient History  Chuck is a 66 year old retired chemical compounder  He is distressed by the.
MODULE 5 1/26 Case 6: Anthony. MODULE 5 Case 6: Anthony 2/26 Patient History  Anthony is a 55-year old lawyer.  He has been suffering from voiding complaints.
CA of Prostate:Incidence In a 50 y/o man In a 50 y/o man In autopsy: 40% In autopsy: 40% Clinical: 10% Clinical: 10% Death: 3% Death: 3% Most common non-cutanous.
In biochemical recurrence after curative treatment of prostate cancer, Choline PET/CT 1- has a detection rate of 10-20% when PSA: 1-2 ng/ml 2- has a detection.
Benign Prostatic Hyperplasia Dr.Bandar Al Hubaishy Urology Department KAUH.
Urinary Path Review.
SVC Syndrome Sung Chul Hwang, M.D. Dept. of Pulmonary and Critical Care Medicine Ajou University School of Medicine.
E Case 8 SVNGMC YAVATMAL DEPT. OF PATHOLOGY. CASE HISTORY A 33 year old man presented with extensive skin lesions all over body mainly involving face.
A PRACTICAL GUIDE TO PSA SCREENING Kendall Itoku, MD St. Louis Urological Surgeons.
Prostate Cancer Int. 洪 毓 謙. Prostate cancer is the Second leading cause of death from cancer in the United States American male, the lifetime risk of:
8/14/2015.  Urinary tract infections (UTIs) are caused by pathogenic microorganisms in the urinary tract (the normal urinary tract is sterile above the.
Waleed Awwad, MD, FRCSC. Red Flags: Red Flags: History of cancer History of cancer Unexplained weight loss >10 kg within 6 months Unexplained weight.
Prostate Cancer Screening Assistant Professor Charles Chabert Men’s health Seminar Ballina April 2011 prostates.com.au.
Approach to a thyroid nodule
Professor Abhay Rane OBE
MedPix Medical Image Database COW - Case of the Week Case Contributor: Jason Blitz Affiliation: Uniformed Services University.
MedPix Medical Image Database COW - Case of the Week Case Contributor: Paul J Cunningham Affiliation: Madigan Army Medical Center.
Should I have that blood test for Prostate Cancer?
Prostate Cancer Case Presentation Shireen Siddiqui.
Surrogate End point for Prostate Cancer- Specific Mortality After RP or EBRT A D’Amico J Nat Ca Inst 95,
Urology Update Sanofi- Aventis
Prostate cancer Tim Bracey Histopathology. Prostate cancer What are we going to talk about? Anatomy of prostate Anatomy of prostate Very basic histology!
Prostate Cancer Prostate cancer is the most common cancer detected in American men. The lifetime risk of a 50-year-old man for latent CaP is 40%; for.
A 74 year old man underwent open prostatectomy due to moderate to severe urinary symptoms unresponsive to medical therapy. Preoperative PSA was 4.1 Postoperatively.
NYU Medical Grand Rounds Clinical Vignette Josie Ni, PGY-3 9/13/11 U NITED S TATES D EPARTMENT OF V ETERANS A FFAIRS.
Carcinoma of prostate 1. Incidence ❏ most prevalent cancer in males ❏ second leading cause of male cancer deaths ❏ lifetime risk of a 50 years man for.
Design of Clinical Trials for Select Patients With a Rising PSA following Primary Therapy Anthony V. D’Amico, MD, PhD Professor of Radiation Oncology Harvard.
Bladder cancer. Urothelial tumors -90% in bladder -8% renal pelvis -2% ureters and urethra.
EUROPA UOMO European Prostate Passport Recommendations from Berlin
PROSTATE CANCER: RADIATION APPROACHES for advanced disease
Case presentation Death and Complications Conference Keri Quinn 6/28/12.
CASE 1 65-year-old man No other diseases or previous surgeries July 2005: PSA 11.5 ng/ml; F/T: 9% After prostate biopsy revealing adenocarcinoma: RETROPUBIC.
PSA Testing Importance of Multiple Markers Ian Thompson MD Department of Urology University of Texas HSC San Antonio, TX.
Figure 1. Gross specimen of prostate gland.. Figure 2. Microscopic effects of BPH.
Pelvic bone tumor Quiz 3. Female 32 C/C: vague pelvic pain P/I: about 6-7 months ago.
Academic day 13/02/2014 MUBARAK ALKABEER HOSPITAL.
WHAT ON EARTH IS MOVEMBER? WHAT ON EARTH IS PROSTATE CANCER? ftjfj.
Prostate Screening in the New Millennium Dr Pamela Ajayi MD PathCare.
Prostate Dr. Amitabha Basu MD.
Slainte an Chlar Health Education Day Cancer 20 th Feb 2010.
بسم الله الرحمن الرحيم. The role of three dimensional transrectal ultrasonography (3-D TRUS) and power Doppler sonography in prostatic lesions evaluation.
LUTS Audit Gopal Krishana Singh. Method Brownhills – Patients Searched all patient on medical treatment Looked at the notes to identify (recorded) – IPSS.
Prostate Cancer. What is the Prostate Gland What is the prostate Gland Size of a chestnut Just beneath the bladder Urethra runs through its middle Its.
B-Late changes In severe degree of obstruction : The intrapelvic pressure becomes closure or higher than the glomerular filtration rate(6-12mm Hg), -less.
Male Genital Tract 1, Case 3 A 72-year-old man presents with back pain. On physical exam there is tenderness over the lower spine. Neurologic exam is normal.
MRI IN PROSTATE CANCER MAHYAR GHAFOORI M.D. Associate Professor of Radiology Tehran University Of Medical Sciences.
Pathology of the Urogenital Tract Male Genital Tract March 24, 2014.
Copyright © 2010 Delmar, Cengage Learning. ALL RIGHTS RESERVED. Chapter 28 Male Reproductive System.
A 50 year old diabetic female presented with burning micturition associated with urinary frequency & suprapubic pain.
Prostate Dr. Atif Ali Bashir MD. Prostate Pathology ► Prostate weighs 20 grams in normal adult ► Retroperitoneal organ,encircling the neck of bladder.
Prostate cancer update Suresh GANTA Consultant urological surgeon Manor Hospital.
Department of Urology, Guangzhou First Municipal People’s Hospital, Guangzhou Medical College, Guangzhou, China Rubiao Ou, Meng You, Ping Tang, Hui Chen,
Date of download: 6/20/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Evaluation of Benign vs Malignant Hepatic Lesions.
Prostate Cancer Awareness In association with. What is Prostate Cancer?
Prostate Cancer David Eedes 11 May Prostate Cancer Definition: Prostate cancer is a disease in which cells in the prostate gland become abnormal.
Carcinoma of Prostate Issam S. Al-Azzawi, MD,FICMS,FEBU By
Prostate cancer นพ.ชัชชัย หอมเกตุ.
Renal stone Summation and Case Presentation
Radio Iodine Therapy In Cancer Thyroid
Pre-session Number2 (Trial-2 /// 8July2013)
دانشگاه شهیدرجایی تهران
تعهدات مشتری در کنوانسیون بیع بین المللی
Prostate cancer Produced by Dr. Magdy M. Awny 2018
Guru Sonpavde, MD, Teresa G. Hayes, MD  Mayo Clinic Proceedings 
Presentation transcript:

Case Presentation HKC 1392

A 78 y/o man obstructive symptoms Flank pain(_) Gross hematuria(-). LUTS(+)

Past history Open prostatectomy 1389/4/27 in Rasoul Akram Hosp. Negative for malignancy

Physical examination Normal DRE:+ 1> /Firm/symmetric/without nodule

Lab data: 1389/8 Cr:1.2 PSA: 41

TRUS GUIDED BIOPSY: 1389/9/27 Adenocarsinom of prostate Rt&Lt base : 4+4, 4+3 (80%, 40%) Rt&Lt upper- mid : 3+4, 3+4 (90%, 70%) Rt&Lt lower- mid : 4+4, 4+4 (80%, 70%) Rt apex : 4+3 ( 50%) Lt apex: benign proststic tissue PNI (+) Extra prostate (-)

Bone scan Multiple bone metastases

Medical therapy DIPHERELIN therapy since 1389/8 monthly & FLUTAMIDE since 1391/10

Thanks for Attention